Published in Hypertension on March 01, 1987
Baroreflex failure following radiation therapy for nasopharyngeal carcinoma. Clin Auton Res (1999) 1.16
Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest (1992) 1.07
Autonomic dysfunction in essential hypertension: A systematic review. Ann Med Surg (Lond) (2013) 0.87
Baroreceptor denervation presenting as part of a vagal mononeuropathy. Clin Auton Res (2000) 0.84
Arterial baroreceptors in the management of systemic hypertension. Med Sci Monit (2010) 0.83
Involvement of vasodilator mechanisms in arterial pressure lability after sino-aortic baroreceptor denervation in rat. J Physiol (1995) 0.82
A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension. PLoS One (2013) 0.81
Evidence for unloading arterial baroreceptors during low levels of lower body negative pressure in humans. Am J Physiol Heart Circ Physiol (2008) 0.81
Carotid baroreflex activation therapy for resistant hypertension. Nat Rev Cardiol (2015) 0.80
Sudden death following selective neuronal lesions in the rat nucleus tractus solitarii. Auton Neurosci (2012) 0.78
Baroreflex dysfunction induced by microgravity: potential relevance to postflight orthostatic intolerance. Clin Auton Res (2000) 0.76
Views of translational research from a somewhat translational scientist. J Investig Med (2012) 0.75
Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med (1999) 4.09
Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res (1985) 3.88
Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A (1998) 3.00
Sympathetic overactivity in patients with chronic renal failure. N Engl J Med (1992) 2.99
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2000) 2.49
Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension (1987) 2.46
Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation (1986) 2.19
Inhibition of alpha 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol (1994) 2.18
Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet (1981) 2.18
Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol (1998) 2.15
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation (1995) 2.08
Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle. Circulation (1995) 2.00
Differential control of heart rate and sympathetic nerve activity during dynamic exercise. Insight from intraneural recordings in humans. J Clin Invest (1987) 1.93
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87
Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med (1990) 1.85
Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest (2001) 1.82
Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient. N Engl J Med (1990) 1.64
ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest (1997) 1.62
Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J (1999) 1.61
Differential sympathetic neural control of oxygenation in resting and exercising human skeletal muscle. J Clin Invest (1996) 1.60
Stimulation of skin sympathetic nerve discharge by central command. Differential control of sympathetic outflow to skin and skeletal muscle during static exercise. Circ Res (1991) 1.56
Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol (1996) 1.54
The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(omega)-nitro-L-arginine methyl ester. Hypertension (1997) 1.52
Continuous positive airway pressure increases heart rate variability in congestive heart failure. J Am Coll Cardiol (1995) 1.51
Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation (1995) 1.49
Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation (2001) 1.48
Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation (1998) 1.48
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation (1997) 1.47
Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress. Circ Res (2001) 1.46
Regulation of muscle sympathetic nerve activity during exercise in humans. Exerc Sport Sci Rev (1991) 1.43
Endorphins and exercise: physiological mechanisms and clinical implications. Med Sci Sports Exerc (1990) 1.43
Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure. Eur Heart J (2002) 1.43
Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med (1996) 1.43
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax (2005) 1.42
Comparison of two indices for forearm noradrenaline release in humans. Clin Sci (Lond) (2000) 1.42
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.42
Metabolic modulation of sympathetic vasoconstriction in human skeletal muscle: role of tissue hypoxia. J Physiol (2000) 1.39
Transmitral velocities measured by pulsed Doppler in healthy volunteers: effects of acute changes in blood pressure and heart rate. Br Heart J (1989) 1.39
Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction. Eur Heart J (2002) 1.38
Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation (1999) 1.37
A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension (1999) 1.33
Sympathetic outflow to resting muscles during static handgrip and postcontraction muscle ischemia. Am J Physiol (1989) 1.31
Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease). J Clin Invest (1990) 1.31
Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart (2009) 1.30
Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res (1999) 1.29
Postexercise hypotension and sympathoinhibition in borderline hypertensive men. Hypertension (1989) 1.28
Muscle metaboreflex triggers parallel sympathetic activation in exercising and resting human skeletal muscle. Am J Physiol (1994) 1.28
Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J (2003) 1.26
Autonomic blockade and cardiovascular responses to static exercise in partially curarized man. J Physiol (1989) 1.22
Cardiovascular complications in renal failure. J Am Soc Nephrol (1991) 1.21
Relative contributions of cardiopulmonary and sinoaortic baroreflexes in causing sympathetic activation in the human skeletal muscle circulation during orthostatic stress. Circ Res (1993) 1.21
Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise. Am J Physiol Heart Circ Physiol (2001) 1.19
Arterial baroreflex buffering of sympathetic activation during exercise-induced elevations in arterial pressure. J Clin Invest (1990) 1.14
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators. Am Heart J (1999) 1.12
Entrainment of blood pressure and heart rate oscillations by periodic breathing. Am J Respir Crit Care Med (1999) 1.11
Shift in sleep apnoea type in heart failure patients in the CANPAP trial. Eur Respir J (2010) 1.10
Behavioural modification of the cholinergic anti-inflammatory response to C-reactive protein in patients with hypertension. J Intern Med (2012) 1.10
Insulin-mediated increase in blood flow is impaired in the elderly. J Clin Endocrinol Metab (1995) 1.10
Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation (1999) 1.09
Mechanisms of cutaneous vasoconstriction during upright posture. Acta Physiol Scand (1997) 1.08
The effect of coronary angioplasty on coronary flow reserve. Circulation (1988) 1.08
Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest (1992) 1.07
Increase of sympathetic discharge to skeletal muscle but not to skin during mild lower body negative pressure in humans. J Physiol (1994) 1.07
Interaction of cardiopulmonary and carotid baroreflex control of vascular resistance in humans. J Clin Invest (1985) 1.06
Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension (1994) 1.04
Overweight and sympathetic overactivity in black Americans. Hypertension (2001) 1.04
Optimal size of cuff bladder for indirect measurement of arterial pressure in adults. J Hypertens (1989) 1.02
One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. Circulation (1999) 1.02
Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Clin Sci (Lond) (1999) 1.00
Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation (2001) 0.99
Defibrillator electrode-chest wall coupling agents: influence on transthoracic impedance and shock success. J Am Coll Cardiol (1985) 0.98
Spontaneous spinal epidural hematoma in a patient with a mechanical aortic valve taking warfarin. Can J Cardiol (1995) 0.98
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci U S A (2000) 0.97
Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. Circulation (2000) 0.97
Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations. Lupus (2004) 0.97
Plasma norepinephrine and muscle sympathetic discharge during rhythmic exercise in humans. J Appl Physiol (1985) (1988) 0.97
Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure. Europace (2001) 0.96
Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension (1995) 0.96
Cardiovascular pharmacology of purines. Clin Sci (Lond) (1997) 0.96
Assessment of the antihypertensive effect of atenolol with 24 h ambulatory monitoring of blood pressure. Clin Sci (Lond) (1979) 0.95
Static muscle contraction reflexly increases adrenal sympathetic nerve activity in rats. Am J Physiol (1991) 0.95
Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc (2001) 0.94
Feasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerized quantitative texture analysis of clinical echocardiographic data. J Am Coll Cardiol (1989) 0.93
Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. Circ Res (1993) 0.91
Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond) (1996) 0.90
Exercise-induced attenuation of alpha-adrenoceptor mediated vasoconstriction in humans: evidence from phase-contrast MRI. Cardiovasc Res (1999) 0.90
Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin. Hypertension (1995) 0.90
Effects of vasopressin on the circulation and its baroreflex control in healthy men. Circulation (1986) 0.90
Neural control of the cardiovascular system: insights from muscle sympathetic nerve recordings in humans. Med Sci Sports Exerc (1996) 0.90
Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol (1985) (1998) 0.89
Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels (1990) 0.88
Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats. Hypertension (1991) 0.88